Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03387462Phase 4Completed
Phase 4, open-label, single-arm trial, sponsored by Heluna Health. Primary endpoints: DOT Diary Mobile App Acceptability at 8 weeks, DOT Diary Mobile App Ease of Use at 8 weeks and 1 more. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03387462.